The completion of a clinical trial marks the end of data collection but not the end of research responsibility. The scientific and ethical value of a trial is realized only...
Applied Artificial Intelligence for Drug Discovery (Springer, 2026) offers a comprehensive, forward looking overview of how AI, machine learning, and deep learning...
Roche has received approval from the US Food and Drug Administration (FDA) for Wilserdly (giredestrant) in combination with everolimus to treat adults with oestrogen...
Bayer is investing US$2.2 billion to establish a new pharmaceutical manufacturing facility in New Albany, Ohio, as part of its strategy to strengthen production capacity...
Asimov, the company building an AI-native synthetic biology platform to advance therapeutic development, and Emergent Biosolutions, a leading global public health company, today...
The US Food and Drug Administration (FDA) has granted Breakthrough Therapy Designation to Juniper Biosciences’ JBS-003 (18F-fluoromisonidazole, or FMISO) for identifying...
Clinical trial data submitted to regulatory authorities must conform to the Study Data Tabulation Model (SDTM) standards maintained by the Clinical Data Interchange...